Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon

International Journal of Infectious Diseases(2023)10.1016/j.ijid.2023.03.050Source: DataRank Database

Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon is a research paper published in International Journal of Infectious Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 5.65)OA: goldTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Akindeh M. Nji ORCID,Jean Paul Kengne Chedjou,Helle Hansson ORCID,Emma Filtenborg Hocke ORCID,Innocent Mbulli Ali ORCID

Live enrichment

PubMed:37028468 PMC:PMC10182900 OpenAlex:https://openalex.org/W4362672518

FIC NIH HHS

Grant: D43 TW009074

FIC NIH HHS

Grant: R25 TW009345

NIAID NIH HHS

Grant: U19 AI089672

Wellcome Trust

Grant: 107741/A/15/Z

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 1D43TW009074-01

Training of Cameroonian Scientists in Research on Malaria

National Institutes of Health

Grant: 2U19AI089672-08

Southeast Asia Malaria Research Center

National Institutes of Health

Grant: 5R25TW009345-02

Northern/Pacific Universities Global Health Research Training Consortium

Wellcome Trust

FWCI

5.65

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ijid.2023.03.050

publisherhttps://doi.org/10.1016/j.ijid.2023.03.050

publisherhttps://api.elsevier.com/content/article/PII:S1201971223001297?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1201971223001297?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37028468

Fields of Study

Malaria Research and ControlPharmaceutical Quality and CounterfeitingHistorical Medical Research and Treatments0303 health sciences03 medical and health sciences

MeSH Terms

AntimalarialsCameroonDrug CombinationsHumansPlasmodium falciparumSulfadoxineProtozoan ProteinsMalaria, FalciparumArtemisinins

Keywords

Plasmodium falciparumArtemisininMalariaDrug resistanceVirologyPiperaquineAmpliconBiologyNested polymerase chain reactionPharmacologyPolymerase chain reactionMedicineGeneticsGeneImmunologyEvolutionCameroonArtemisinin-based Combination TherapiesTargeted Amplicon Deep SequencingProtozoan ProteinsInfectious and parasitic diseasesRC109-216ArticleArtemisininsAntimalarialsDrug CombinationsSulfadoxineHumansMalaria, Falciparum

Sustainable Development Goals

SDG 0: Good health and well-being

Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon

FAIR Checklist

Authors (15)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)